Pfizer is the largest shareholder of Alzheimer's drug developer Cortexyme, which has filed to raise up to $86.3m in its initial public offering.

The digital payment technology provider has been acquired by Naspers subsidiary PayU in a $70m deal that will enable Intel Capital to exit.

Tola Capital led a round that included corporate venturing unit XL Catlin, increasing the commercial insurance provider's overall funding to $42m.

The Recruit-backed customer analytics software provider has secured new funding at a $150m valuation, in a Sequoia India-led round.

Stanford spinout Cardinal Analytx has raised $20.6m out of a targeted $29.3m, adding to a $6.1m series A round backed by Stanford-StartX Fund in 2017.

Asklepios BioPharmaceutical, based on work by UNC Chapel Hill professors Jude Samulski and Xiao Xiao, has secured $235m in funding co-led by TPG Capital and Vida Ventures.

City National Bank took part as Point72 and FinTech Collective co-led the round, which increased the online credit card platform's total funding to more than $14m.

PureTech Health and Mitsubishi Tanabe Pharma took part in the Merck Group-led series A round, which will fund work developing Sonde's voice-based medical monitoring technology.

Salesforce is set to exit IT service desk software provider Samanage in a $350m acquisition by SolarWinds, which will integrate the company's offering into its own product suite.

Used vehicle e-commerce platform Shift has collected another $40m for a series D round that is backed by Lithia Motors, BMW and Alliance Ventures.